Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3176 |
|
Actual shortage: | 259 (8%) | |
Anticipated shortage: | 5 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2903 (91%) | |
Discontinuation Reports |
355 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 333 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
33 (12%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2017-10-03 | 2018-03-15 | 24262 |
APO-LEVOFLOXACIN | 750MG | TABLET | Resolved | 2018-06-04 | 2018-08-09 | 51201 |
APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2018-12-12 | 2018-12-21 | 69307 |
APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2019-02-24 | 2019-04-26 | 76720 |
APO-LEVOFLOXACIN | 750MG | TABLET | Resolved | 2019-07-17 | 2019-12-19 | 89548 |
APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2021-01-18 | 2021-02-26 | 131875 |
APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2021-05-25 | 2021-10-05 | 139845 |
APO-LEVOFLOXACIN | 750MG | TABLET | Resolved | 2022-06-17 | 2022-07-28 | 162907 |
APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2022-08-19 | 2022-08-24 | 167416 |
APO-LEVOFLOXACIN | 750MG | TABLET | Resolved | 2022-11-11 | 2023-01-20 | 174359 |
APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2022-11-20 | 2022-12-23 | 175321 |
APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2023-02-02 | 2023-06-23 | 183477 |
APO-LEVOFLOXACIN | 750MG | TABLET | Resolved | 2023-02-23 | 2023-05-06 | 185468 |
APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2023-09-15 | 2023-10-27 | 204405 |
APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2023-11-17 | 2023-12-15 | 210656 |
APO-LEVOFLOXACIN | 750MG | TABLET | Resolved | 2023-12-06 | 2024-03-08 | 212569 |
APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2024-02-02 | 2024-03-15 | 218370 |
APO-LEVOFLOXACIN | 750MG | TABLET | Resolved | 2024-07-12 | 2024-07-26 | 232829 |
APO-LEVOFLOXACIN | 750MG | TABLET | Actual shortage | 2024-08-22 | 2024-08-29 | 235695 |
APO-IRBESARTAN | 75MG | TABLET | Resolved | 2017-03-10 | 2017-12-14 | 342 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
APO-CETIRIZINE | Discontinued | 2018-05-31 | 2018-05-31 | 50998 | ||
APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-09-07 | 2018-09-15 | 60241 | ||
APO-CYCLOSPORINE ORAL SOLUTION | Discontinued | 2018-09-07 | 2018-09-15 | 60408 | ||
APO-FAMOTIDINE TAB 20MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60477 | ||
APO-FAMOTIDINE TAB 40MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60480 | ||
APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
APO-RIZATRIPTAN RPD | Discontinued | 2018-09-08 | 2019-04-02 | 60756 | ||
APO-SILDENAFIL R | Discontinued | 2018-09-08 | 2018-09-15 | 60787 | ||
APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-12-21 | 2018-12-24 | 70347 | ||
APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
ACID CONTROL | Discontinued | 2019-01-03 | 2019-01-03 | 70906 | ||
APO-OFLOXACIN | Discontinued | 2019-01-03 | 2019-01-03 | 71017 | ||
APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 |